HOUSTON, Sept. 18 /PRNewswire/ -- Today US Oncology, Inc., which supports the nation’s foremost cancer treatment and research network, announced the appointment of Michael A. Sicuro as Executive Vice President and Chief Financial Officer. In this position Sicuro will lead and manage the finance function and provide leadership on a wide range of financial, analytical, operational, and transactional issues, including accounting, financial reporting, treasury, tax, and financial planning and analysis.
Sicuro comes to US Oncology with more than 25 years of financial and operating experience in a variety of industries including health care, technology, financial services and real estate. Most recently he was Senior Vice President, Chief Financial Officer at Asyst Technologies, Inc., a global automation and technology company. Sicuro holds a Bachelor of Business Administration degree from Kent State University.
“Michael brings a wealth of knowledge and leadership to US Oncology and we are very pleased to have him as part of our team,” said Bruce Broussard, President and Chief Executive Officer of US Oncology. “His expertise and experience will continue to create operational efficiencies that will only improve upon our strong performance and ensure our goal to enhance patient access to advanced cancer care through all phases of the delivery system.”
“I am very excited to join the US Oncology team. The strength of this company is a testament to its dedication and commitment to increase access to high quality cancer care to patients,” said Sicuro. “I’m looking forward to working to identify strategic opportunities that will support and strengthen these goals.”
Sicuro is based at the company’s headquarters in Houston, Texas.
About US Oncology
US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation’s foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology’s expertise in supporting every aspect of the cancer care delivery system-from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company’s last quarterly earnings report, US Oncology is affiliated with 1,220 physicians operating in 480 locations, including 92 radiation oncology facilities in 39 states. For more information, visit the company’s Web site, http://www.usoncology.com.
CONTACT: Lisa Henderson of Hill & Knowlton, Inc., +1-813-775-6208,
Lisa.Henderson@hillandknowlton.com, for US Oncology, Inc.
Web site: http://www.usoncology.com/
